Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $3.28 in the prior trading day, Revance Therapeutics Inc (NASDAQ: RVNC) closed at $3.27, down -0.30%. In other words, the price has decreased by -$0.30 from its previous closing price. On the day, 0.66 million shares were traded. RVNC stock price reached its highest trading level at $3.3 during the session, while it also had its lowest trading level at $3.255.
Ratios:
Our goal is to gain a better understanding of RVNC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.05 and its Current Ratio is at 4.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $16 previously.
On January 09, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $30 to $8.
Exane BNP Paribas Upgraded its Underperform to Neutral on August 16, 2023, while the target price for the stock was maintained at $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’24 when Hollander David sold 3,908 shares for $4.17 per share. The transaction valued at 16,296 led to the insider holds 104,945 shares of the business.
Jordan Erica sold 2,392 shares of RVNC for $9,096 on Apr 16 ’24. The Chief Commercial Officer now owns 114,864 shares after completing the transaction at $3.80 per share. On Mar 18 ’24, another insider, Sjuts Dustin S, who serves as the President of the company, sold 9,211 shares for $5.04 each. As a result, the insider received 46,446 and left with 167,550 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVNC now has a Market Capitalization of 341355296 and an Enterprise Value of 642401792. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.38. Its current Enterprise Value per Revenue stands at 2.5 whereas that against EBITDA is -3.424.
Stock Price History:
The Beta on a monthly basis for RVNC is 0.89, which has changed by -0.42049468 over the last 52 weeks, in comparison to a change of 0.22677135 over the same period for the S&P500. Over the past 52 weeks, RVNC has reached a high of $7.56, while it has fallen to a 52-week low of $2.30. The 50-Day Moving Average of the stock is -10.65%, while the 200-Day Moving Average is calculated to be -22.14%.
Shares Statistics:
The stock has traded on average 2.82M shares per day over the past 3-months and 3179370 shares per day over the last 10 days, according to various share statistics. A total of 104.90M shares are outstanding, with a floating share count of 95.25M. Insiders hold about 8.76% of the company’s shares, while institutions hold 85.60% stake in the company. Shares short for RVNC as of 1735603200 were 8341091 with a Short Ratio of 2.96, compared to 1732838400 on 12703555. Therefore, it implies a Short% of Shares Outstanding of 8341091 and a Short% of Float of 9.17.
